Myocardial Infarction
📧 Sign up to get email alerts when something new happens for Myocardial Infarction.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2016-02-23FDA Approved: CAPTOPRIL — Supplemental Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved a supplemental application for CAPTOPRIL from Hikma Pharmaceuticals USA Inc.
-
CLINICAL_TRIALS other · 2016-02-23Clinical Trial Update: Using Magnetic Resonance Imaging to Evaluate Heart Vessel Function After Angioplasty or Stent Placement Procedures
A completed clinical trial update describes using magnetic resonance imaging to evaluate heart vessel function after angioplasty or stent pl…
-
CLINICAL_TRIALS trial_result · 2016-02-22Clinical Trial Update: A Study to Evaluate the Use of Mobile-phone Based Patient Support in Patients Diagnosed With Myocardial Infarction [NA]
AstraZeneca-sponsored trial evaluating a mobile-phone based patient support program in patients with myocardial infarction has completed and…
-
FDA label_change · 2016-02-18FDA Approved: LISINOPRIL — Supplemental Application (Exelan Pharmaceuticals Inc.)
The FDA approved a supplemental application for lisinopril submitted by Exelan Pharmaceuticals Inc., typically resulting in labeling updates…
-
FDA approval · 2016-02-18FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for enalapril maleate from Northstar RxLLC. The approval confirms changes associated with this gener…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Stroke and MI in Users of Estrogen/Progestogen
This completed NHLBI trial updates findings on the risk of stroke and myocardial infarction in users of estrogen/progestin hormone therapy.
-
FDA approval · 2016-02-18FDA Approved: QUINAPRIL — Supplemental Application (BluePoint Laboratories)
The FDA approved a supplemental application for Quinapril submitted by BluePoint Laboratories. The action updates the drug’s labeling.
-
FDA approval · 2016-02-18FDA Approved: ENALAPRIL MALEATE — Supplemental Application (Northstar RxLLC)
FDA approved a supplemental application for Enalapril Maleate from Northstar RxLLC under an ANDA.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Novel Hemostatic Cardiac Risk Factors in Framingham
An NHLBI-sponsored Framingham clinical trial investigated novel hemostatic factors as cardiac risk factors; the study has completed, examini…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Mediators of Social Support in Coronary Disease
A completed NHLBI-sponsored clinical trial investigated how social support mediates outcomes in coronary disease and related cardiovascular …
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Homocysteine and Progression of Atherosclerosis
This is an update on a completed NHLBI clinical trial studying how homocysteine levels relate to the progression of atherosclerosis. The stu…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Epidemiology of Coronary Heart Disease in Blacks
NHLBI-sponsored epidemiology study on coronary heart disease in Black individuals has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Physical Activity and Cardiovascular Disease Prevention
This entry reports the completion of an NHLBI-sponsored clinical trial evaluating physical activity for the prevention of cardiovascular dis…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Vascular Interaction With Age in Myocardial Infarction [NA]
The National Heart, Lung, and Blood Institute–sponsored trial on vascular interaction with age in myocardial infarction has completed.
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Insulin and Biogenic Amines in Cardiovascular Disease
A completed clinical trial update examining the role of insulin and biogenic amines in cardiovascular diseases, including hypertension, obes…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Clinical Course of Coronary Artery Disease Among Blacks
An NHLBI-funded trial update assesses the clinical course of coronary artery disease among Black participants. The study status is completed…
-
CLINICAL_TRIALS trial_result · 2016-02-18Clinical Trial Update: Infection and Cardiovascular Disease
Clinical trial update indicating the NHLBI study on infections and cardiovascular disease has completed. The provided excerpt does not inclu…
-
CLINICAL_TRIALS research · 2016-02-17Clinical Trial Update: Evaluation of Novel Risk Factors and Clinical Outcomes of Acute Myocardial Infarction
An ongoing clinical trial from Zhejiang Provincial People's Hospital investigates novel risk factors and clinical outcomes in acute myocardi…
-
CLINICAL_TRIALS trial_result · 2016-02-17Clinical Trial Update: Identification of the Blood Microbiota in Patient Suffering From Myocardial Infraction
A completed clinical trial examining the blood microbiota in patients with myocardial infarction, exploring microbial signatures in the cont…
-
FDA approval · 2016-02-16FDA Approved: CAPTOPRIL — Supplemental Application (Camber Pharmaceuticals, Inc.)
FDA approves Camber Pharmaceuticals' supplemental application for CAPTOPRIL (captopril) under an existing ANDA. The action confirms continue…
-
CLINICAL_TRIALS trial_result · 2016-02-12Clinical Trial Update: Alpha-1 Anti-Trypsin (AAT) Treatment in Acute Myocardial Infarction [Phase 1, Phase 2]
A clinical trial evaluated alpha-1 antitrypsin therapy in patients with acute myocardial infarction in Phase 1 and Phase 2. The study is com…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Intravenous Streptokinase in Acute Myocardial Infarction [Phase 3]
Phase 3 trial evaluating intravenous streptokinase for acute myocardial infarction has completed enrollment; final results are pending.
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Postmenopausal Progestins, MI and Stroke
This completed clinical trial update investigates postmenopausal progestins and their association with myocardial infarction and stroke risk…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Common Variants in Candidate Genes and Premature MI Risk
A completed clinical trial evaluated whether common genetic variants in candidate genes influence the risk of premature myocardial infarctio…
-
CLINICAL_TRIALS trial_result · 2016-02-10Clinical Trial Update: Effect of Drug Therapy on Reinfarction Risk in Women
A completed clinical trial investigates whether a drug therapy reduces the risk of reinfarction in women after a myocardial infarction.